CD44 and Menkes disease: On the other hand, IP6 treatment was able to induce a significant decrease in the expression of CD44 (p ≤ 0.01, both MD and PD stages) and BMI-1 (p ≤ 0.001, MD stage; p ≤ 0.05, PD stage).